Antineoplastic activity of synthetic lysophospholipid analogs.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008244:Lysophosphatidylcholines / Q000494:pharmacology; D008246:Lysophospholipids; D009101:Multiple Myeloma / Q000188:drug therapy; D009362:Neoplasm Metastasis; D009374:Neoplasms, Experimental / Q000188:drug therapy; D010743:Phospholipids / Q000494:pharmacology* / Q000627:therapeutic use; D012513:Sarcoma, Experimental / Q000188:drug therapy
D000970:Antineoplastic Agents; D008244:Lysophosphatidylcholines; D008246:Lysophospholipids; D010743:Phospholipids